Moderna’s Shift to Cancer Company Lifts Stock Up 177%

Scritto il 20/08/2026
da Rebecca Robbins

The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.A lab at Moderna’s headquarters in Cambridge, Mass., in 2024.